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DISCUSSION 
	

	
Throughout  the  somatosensory  desensitization  (SD)  protocol  and  seven  months  following  the  treatment,  the  participant 
experienced a general trend of greater improvements in treated versus untreated limbs of all studied outcomes. Changes observed in pain 
body diagrams revealed  that  as  pain  decreased,  paresthesias  and  numbness  increased,  indicating  a  transformation  towards  normal 
sensation. As pain intensity and distribution decreased, there was also a corresponding improvement in somatosensation of proximal 
areas, even though those areas were not directly treated. Prior to the SD, the participant’s neuromatrix may have been reorganized in a 
way such that more of his somatosensory homunculus was devoted to painful distal areas, effectively cramming out the representation of 
non-painful proximal areas. Secondary to the treatment, the participant may have undergone a process of central reorganization, where 
those underrepresented areas were gradually normalized. Improvements were also noted in untreated limbs, most notably with Semmes 
Weinstein monofilament testing, two-point discrimination, and allodynia. This suggests that an overall central desensitization may occur 
in response to SD regardless of where exactly the treatment is applied.	

	
The patient also improved with more functional measures, which suggests not only a decrease in pain, but also a reduction in fear 
of symptom provocation.  CRPS is often exacerbated by fear-avoidance behavior, so the ability to weight bear more heavily through 
limbs that used to be too painful to even touch is indicative of a return towards an improved level of function. Improvements in pinch 
and grip strength were likely due to a decrease in allodynia, though muscular atrophy due to non-use may have been a factor, as well. 
The changes observed in these two outcome measures have obvious functional implications, and are representative of the gains that the 
participant made as a whole.	

                      ​While the data suggests a consistent trend towards improvement across all outcome measures overall, the participant did 
experience a notable spike in symptoms that occurred during his fifth visit. This may have been due to a pacing issue, in which he likely 
overexerted himself the day before the visit due to improving so rapidly following five years of constant pain. Despite this setback, the 
patient again responded well to treatment and continued on the path towards his previous level of function.	

Figure 2.  Baseline (3/13/2001)	

Figure 3.  7-month F/U (2/4/2002)	
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INTRODUCTION 
  
 Complex  regional  pain  syndrome  (CRPS)  is  a 
chronic condition involving allodynia,  constant limb pain, 
and  hyperpathic  autonomic  and  somatic  symptoms  that 
affects at least one extremity and can develop after injury.1 
The  five  types  of  allodynia  are  tactile,  pressure,  thermal, 
vibratory,  and  chemical,  with  tactile  being  the  most 
associated with CRPS.  The kinesiophobia that results from 
allodynia  may  cause  decreased  movement  and  excessive 
guarding  from  even  the  most  delicate  contact,  such  as 
wearing clothing over the affected region.2, 3 Learned non-
use  may  then  lead  to  a  multitude  of  sequelae,  including 
central  sensitization  and  plastic  remodeling  of  the 
neuromatrix  of  pain,  which  can  further  exacerbate 
conditions.4,5	

	
Conventional  therapy  for  CRPS  varies  greatly, 
however,  only some forms of  treatment  are  supported by 
evidence.6,7  Within  the  last  decade,  somatosensory 
desensitization (SD) has been shown to be effective in the 
treatment  of  CRPS  and  is  considered  to  be  an  essential 
component in restoring function.2,3,8 SD is a functional form 
of  physical  therapy  involving  the  management  of  pain 
avoidance  behavior  by  repeated  exposure  to  increasingly 
coarser and irritating materials to the affected regions.1 This 
treatment typically involves a 10 to 15 week protocol, much 
of which is self-massage that can be done at home.2	

	
The mechanism of SD is still unclear, but the goal is 
to decrease pain,  allodynia,  and kinesiophobia so that  the 
patient  will  increase  self-confidence  and  contact  with  the 
external environment in order to improve functional use of 
the  affected  limb.2,3  While  desensitization  is  considered 
standard care for CRPS and there is evidence of decreased 
pain  and  allodynia  in  the  affected  limb,  research  is  still 
limited.2,3	

	

	

	

	

	

	

	

	

	

	

PURPOSE	

	

	
The purpose of  this  case study is  to  determine the 
effectiveness of somatosensory desensitization in reducing 
the intensity and distribution of pain and tactile allodynia as 
measured by visual analog scales and pain body diagrams, 
as  well  as  to  assess  changes  in  Semmes  Weinstein 
monofilament testing, two point discrimination, algometry, 
grip  and  pinch  strength,  and  weight  bearing  symmetry. 
Additionally,  we  aim  to  add  to  the  body  of  literature 
regarding  duration,  frequency,  types  and  progression  of 
materials used in the desensitization treatment.	
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CASE DESCRIPTION	

	

	
The 54 y.o. male patient had an incomplete C5 SCI. 
Prior  to  somatosensory  desensitization,  the  patient 
experienced constant searing pain and tactile allodynia in all 
limbs for five years following the diagnosis of type II CRPS, 
despite  18 months  of  early  physical  therapy that  restored 
nearly  full  functional  mobility.  Quadrilateral  involvement 
permitted researchers  to desensitize one upper (right)  and 
one lower (left) limb. 
Figure 1.  Example of graded tactile 	

 desensitization with rotini noodles	

	

METHODS 
 
 Following three weekly baseline assessment sessions, 
the patient participated in a ten-week treatment program of 
progressive tactile desensitization, applied to the distal right 
upper and left  lower limb via self-massage two times per 
day. The patient completed pain body diagrams (PBD), from 
which pain distribution scores (PDS) were derived  using the 
modified rule-of-nines.  This method divides the body into 
46  segments  where  each  segment  accounts  for  a  certain 
percentage of the body, allowing for a total percentage of 
the  distribution  of  pain  experienced  by  the  patient  to  be 
quantified.9  Other  weekly  outcome  measures  included 
individual visual analog pain scales (VAS) for each limb,  
Semmes-Weinstein  monofilament  testing,   two-point 
discrimination, allodynia measurements via algometry, grip 
and  pinch  strength,  and  weight  bearing  symmetry. 
Monofilament  testing,  two-point  discrimination,  and 
algometry were assessed at both proximal (P) and distal (D) 
areas of each limb.	

 
	

PAIN DISTRIBUTION	

Whole body: 	

Pain↓ 23.5%      Numbness↓ 5.5%       Paresthesias ↑10.5%	

Treated limbs:	

Pain↓ 9.5%        Numbness↓ 4.5%       Paresthesias ↑ 3.0%	

Untreated limbs:	

Pain↓ 14.0%      Numbness↓ 1.0%       Paresthesias ↑ 7.5%	

	

VISUAL ANALOG PAIN SCALE	

Treated Limbs: ↓ 3.95 cm 	
 	
      Untreated Limbs: ↑ 0.45 cm	

	

SEMMES-WEINSTEIN	

Treated Limbs (P):  ↓ 3 sizes 	
 	
      Untreated Limbs (P): ↓ 4 sizes	

Treated Limbs (D): ↑ 2 sizes 	
 	
      Untreated Limbs (D):↑ 1 size	

	

TWO-POINT DISCRIMINATION	

Treated Limbs (P): ↓ 14 mm 	
 	
      Untreated Limbs (P): ↓ 5.2 mm	

Treated Limbs (D):↓ 0.5 mm	
 	
      Untreated Limbs (D):↓ 1.9 mm	

	

ALGOMETRY	

Treated Limbs (P):  > 60 kg 	
 	
      Untreated Limbs (P):  > 60 kg	

Treated Limbs (D):↑ 14.3 kg 	
 	
      Untreated Limbs (D):↑ 4.8 kg	

	

GRIP STRENGTH	

Treated Limb: ↑ 25.7 kg 	
 	
      Untreated Limb: ↑ 3.3 kg	

	

PINCH STRENGTH	

Treated Limb: ↑ 5.7 kg	
 	
 	
      Untreated Limb: ↑ 1.1 kg	

	

WEIGHT BEARING SYMMETRY	

Treated Upper Limb: ↑ 19.2 kg 	
      Untreated Upper Limb: ↑ 4.5 kg	

Treated Lower Limb: ↑ 3.8 kg 	
      Untreated Lower Limb: ↓ 5.3 kg	

	

RESULTS	
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